VSBC (VitaSpring Biomedical Co) EV-to-EBITDA : 2,772.34 (As of Jul. 05, 2025)

VitaSpring Biomedical Co EV-to-EBITDA Chart

VitaSpring Biomedical Co Quarterly Data
	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22
EV-to-EBITDA	Get a 7-Day Free Trial															-69,594.65	1,938.09	1,866.35	2,755.00	2,573.09

Competitive Comparison of VitaSpring Biomedical Co's EV-to-EBITDA

For the Biotechnology subindustry, VitaSpring Biomedical Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VitaSpring Biomedical Co's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VitaSpring Biomedical Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where VitaSpring Biomedical Co's EV-to-EBITDA falls into.

VitaSpring Biomedical Co EV-to-EBITDA Calculation

VitaSpring Biomedical Co's EV-to-EBITDA for today is calculated as:

VitaSpring Biomedical Co's current Enterprise Value is $3,304.63 Mil.
VitaSpring Biomedical Co's EBITDA for the trailing twelve months (TTM) ended in Oct. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VitaSpring Biomedical Co  (OTCPK:VSBC) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

VitaSpring Biomedical Co's PE Ratio (TTM) for today is calculated as:

VitaSpring Biomedical Co's share price for today is $1.00.
VitaSpring Biomedical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.004.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

VitaSpring Biomedical Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of VitaSpring Biomedical Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

VitaSpring Biomedical Co Business Description